JD

Jerel Davis

Managing Director at Versant Ventures

Greater Vancouver Metropolitan Area

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Biotechnology
Pharmaceutical Industry
Medical Devices
R&D
Strategy
Pricing
Molecular Diagnostics
Lifesciences
Corporate Development
Venture Capital
Due Diligence
Business Strategy
Start-ups
Mergers
Entrepreneurship
Life Sciences
Product Management
Strategic Planning
Financial Modeling
Commercialization

Education

Work Experience

  • Managing Director

    2011

    Current companies: Ventus Tx, Turnstone, Tentarix, Santa Ana Bio, FireFly Tx, Kolm Tx, Fable Tx Previous companies: Chinook Tx (KDNY), RayzeBio, (RYZB), BlueRock (Acq. Bayer), Crispr Tx (CRSP), Repare Tx (RPTX), Quanticel Pharmaceuticals (Acq. Celgene), Akero Therapeutics (AKRO), Inception 4 (Acq. Iveric), Inception 5 (Acq. Roche), Northern Biologics (Acq. AZ and BI), Nested Tx, Graphite Bio

  • Board Chair

    2020

  • Board Member

    2022

  • Board Member

    2022

  • Board Member

    2020

  • Board Member

    2015

  • Board Member

    2020

  • Board Member

    2022 - 2023

  • Lead Board Director

    2019 - 2023

2020 - 2023

  • Board Member

    2020 - 2023